Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Solon Eiendom ASA : Sales in Q1 2018

Solon Eiendom ASA
Posted on: 03 Apr 18

Oslo, April 3, 2018 - Solon Eiendom sold 124 homes with a total sales value of NOK 819 million during the first quarter of 2018 compared to 58 homes with a total sales value of NOK 407 million in the first quarter of 2017.

Q1 2018 sales are all time for the company as a result of highly successful sales starts for our projects in Ski, Nesodden and Lier. At quarter end, 96% of the 145 planned deliveries in 2018 have already been sold.

In Q1 2018, 86 homes were completed, 84 delivered, compared to 27 completed, and 24 delivered in Q1 2017. Adjusted for Solon Eiendom's share of joint ventures, sales in Q1 2018 amounted to 114 homes worth NOK 724 million.

The company had 189 homes under construction at March 31, 2018.

For further information, please contact:
Andreas Martinussen, Chief Executive Officer, Solon Eiendom ASA
Tel:     +47 400 00 405, email:

Scott Danielsen, Chief Financial Officer, Solon Eiendom ASA
Tel:     +47 952 55 620, email:

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Solon Eiendom ASA via GlobeNewswire

Last updated on: 04/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.